Reversible Pulpitis
34
5
7
13
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
2.9%
1 terminated out of 34 trials
92.9%
+6.4% vs benchmark
18%
6 trials in Phase 3/4
15%
2 of 13 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 13 completed trials
Clinical Trials (34)
Predicting Vital Pulp Treatment Outcomes in Symptomatic Pulpits Using Metabolic Biomarker
Comparative Evaluation of Calcium Silicate-doped Treated Dentin Matrix and Mineral Trioxide Aggregate as Miniature Pulpotomy Biomaterials in Deep Carious Lesions
In Vivo Pulp Thermal Changes During Different Slenderization Techniques
Comparative Evaluation of Indirect vs. Direct Pulp Capping in Deep Carious Mandibular Molars
Outcome of Direct Pulp Capping and Partial Pulpotomy in Reversible Pulpitis
Comparison of IL-8, FGF-1 and VEGF Levels in Pulpal Tissue, GCF and Dentinal Fluid Samples of Healthy, Reversible and Irreversible Pulpitis Diagnosed Teeth
Cytokines as Diagnostic Markers of Pulpal Inflammation and Their Impact on the Outcome of Vital Pulp Therapy
Pain Management in Teeth With Reversible Pulpitis
Effectiveness of Biodentine v/s Calcium Hydroxide as Indirect Pulp Capping Materials
Assessment of Pain and Anxiety During Infiltration Anesthesia Using Dental Anesthesia Injector Versus Conventional Syringe in Pediatric Patients
Evaluation of Pulpal Biomarkers in Vital Pulp Therapy
Clinical and Radiographic Outcomes of Pulpotomy in Teeth with Different Symptoms and Root Stages
The Effect of Different Risk Factors on the Success Rate of VPT
Caries Location and Its Effect on the Success Rate of Indirect Pulp Treatment in Primary Molars
Direct Pulp Capping Agent on Human Pulp Tissue
Role Of Wound Lavage in Direct Pulp Capping Of Permanent Teeth With Carious Exposure
Pulp Capping in Primary Molars Using TheraCal (LC)
Management of Deep Carious Lesions in Adults
Conservative Pulp Therapy of Primary Molars Using TheraCAL
Survival Rate After TheraCal PT Pulpotomy Versus MTA Pulpotomy in Children With Vital Primary Molars.